TCL Archive In Brief: ACS Appoints Directors For Government Relations And Grassroots Development April 25, 1997
TCL Archive In Brief: AMOS Says Cancer Program Should Not Have Ceiling Of $1 Billion; OSHA Drops Effort To Fire Infants August 14, 1981
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds July 21, 1995
